STEWART MARTIN STEWART.MARTIN@NOTTINGHAM.AC.UK
Professor of Cancer and Radiation Biology
Thioredoxin system protein expression is associated with poor clinical outcome in adult and paediatric gliomas and medulloblastomas
Martin, Stewart; Yao, Anqi; Storr, Sarah J; Al-Hadyan, Khaled; Rahman, Ruman; Smith, Stuart; Grundy, Richard; Paine, Simon
Authors
Anqi Yao
SARAH STORR sarah.storr@nottingham.ac.uk
Assistant Professor
Khaled Al-Hadyan
RUMAN RAHMAN RUMAN.RAHMAN@NOTTINGHAM.AC.UK
Professor of Molecular Neuro-Oncology
STUART SMITH stuart.smith@nottingham.ac.uk
Clinical Associate Professor
RICHARD GRUNDY richard.grundy@nottingham.ac.uk
Professor of Paediatric Neuro-Oncology
Simon Paine
Abstract
The thioredoxin (Trx) system is an important enzyme family that regulates cellular redox homeostasis. Protein expression of Trx system family members has been assessed in various cancers and linked to various clinicopathological variables, disease progression, treatment response and survival outcomes but information is lacking in brain tumours. Expression of the system was therefore examined, by immunohistochemistry in different brain tumour types, adult and paediatric cases, to determine if expression was of importance to clinical outcome. Trx system proteins were expressed, to variable levels, across all brain tumour types with significant variations in expression between different tumour types/grades/regions. High Trx reductase (TrxR) expression was linked to worse prognosis across all cohorts. High cytoplasmic TrxR expression was significantly associated with adverse overall survival (OS) in adult glioblastoma (P=0.027) and paediatric low-grade glioma (LGG) patients (P=0.012). High expression of nuclear TrxR, cytoplasmic and nuclear Trx, and Trxinteracting protein (TxNIP) was associated with improved OS in paediatric LGGs (P=0.031, P
Citation
Martin, S., Yao, A., Storr, S. J., Al-Hadyan, K., Rahman, R., Smith, S., …Paine, S. (2020). Thioredoxin system protein expression is associated with poor clinical outcome in adult and paediatric gliomas and medulloblastomas. Molecular Neurobiology, 57(7), 2889–2901. https://doi.org/10.1007/s12035-020-01928-z
Journal Article Type | Article |
---|---|
Acceptance Date | May 1, 2020 |
Online Publication Date | May 16, 2020 |
Publication Date | May 16, 2020 |
Deposit Date | May 7, 2020 |
Publicly Available Date | May 19, 2020 |
Journal | Molecular Neurobiology |
Print ISSN | 0893-7648 |
Electronic ISSN | 1559-1182 |
Publisher | Springer Verlag |
Peer Reviewed | Peer Reviewed |
Volume | 57 |
Issue | 7 |
Pages | 2889–2901 |
DOI | https://doi.org/10.1007/s12035-020-01928-z |
Keywords | Thioredoxin; Thioredoxin Reductase; glioblastoma; Low-grade glioma; High-grade glioma; Medulloblastoma |
Public URL | https://nottingham-repository.worktribe.com/output/4389172 |
Publisher URL | https://link.springer.com/article/10.1007/s12035-020-01928-z |
Files
Thioredoxin System Protein Expression Is Associated with
(9.4 Mb)
PDF
Publisher Licence URL
https://creativecommons.org/licenses/by/4.0/
You might also like
Germ-line and somatic DICER1 mutations in pineoblastoma
(2014)
Journal Article
Processed pseudogenes acquired somatically during cancer development
(2014)
Journal Article
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search